QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 限定条件 发表日期：2019    专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high-risk HPV-positive women 期刊论文 2019, 卷号: 8, 期号: 10, 页码: 4845-4851 作者:  Chen Xiaojun;  Wei Sun;  Ma Hongxia;  Jin Guangfu;  Hu Zhibin 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 biomarker  cervical cancer  human papillomavirus  telomere   Sorafenib Therapy Is Associated with Improved Outcomes for FMS-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation 期刊论文 2019, 卷号: 25, 期号: 8, 页码: 1674-1681 作者:  Xuan Li;  Wang Yu;  Chen Jia;  Jiang Erlie;  Gao Li 收藏  |  浏览/下载：17/0  |  提交时间：2020/01/03 Acute myeloid leukemia  Allogeneic hematopoietic stem cell transplantation  FMS-like tyrosine kinase 3 internal tandem duplication  Relapse  Sorafenib   Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China A Randomized Clinical Trial 期刊论文 2019, 卷号: 4, 期号: 5, 页码: 418-427 作者:  Wu, Yangfeng;  Li, Shenshen;  Patel, Anushka;  Li, Xian;  Du, Xin 收藏  |  浏览/下载：222/0  |  提交时间：2020/01/03 Sorafenib therapy is associated with improved outcomes for FLT3-ITD AML relapsing after allo-HSCT 期刊论文 2019 作者:  Xuan Li;  Wang Yu;  Chen Jia;  Jiang Erlie;  Gao Li 收藏  |  浏览/下载：21/0  |  提交时间：2020/01/03 FMS-like tyrosine kinase 3 internal tandem duplication  acute myeloid leukemia  allogeneic hematopoietic stem cell transplantation  relapse  sorafenib   Efficacy and safety of ranibizumab 0.5 mg in Chinese patients with visual impairment due to diabetic macular edema: results from the 12-month REFINE study 期刊论文 2019, 卷号: 257, 期号: 3, 页码: 529-541 作者:  Li, Xiaoxin;  Dai, Hong;  Li, Xiaorong;  Han, Mei;  Li, Jun 收藏  |  浏览/下载：175/0  |  提交时间：2020/01/03 Anti-vascular endothelial growth factor  Diabetic macular edema  Pro re nata  Ranibizumab